NEPH Key Statistics, Chart & Performance
The current stock price of NEPH is 5.6648 USD. In the past month the price increased by 1.67%. In the past year, price increased by 259.12%.
NEPH Latest News, Press Relases and Analysis
NEPH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 31.01 | 111.06B | ||
| ITW | ILLINOIS TOOL WORKS | 24.27 | 72.59B | ||
| SYM | SYMBOTIC INC | 95.1 | 35.38B | ||
| XYL | XYLEM INC | 28.68 | 33.79B | ||
| OTIS | OTIS WORLDWIDE CORP | 21.86 | 33.65B | ||
| IR | INGERSOLL-RAND INC | 24.78 | 31.53B | ||
| DOV | DOVER CORP | 20.51 | 26.18B | ||
| SNA | SNAP-ON INC | 18.19 | 18.04B | ||
| FTV | FORTIVE CORP | 16.39 | 17.08B | ||
| ITT | ITT INC | 28.39 | 14.11B | ||
| RBC | RBC BEARINGS INC | 40.79 | 14.04B | ||
| GGG | GRACO INC | 29.63 | 13.86B |
Related stock screener links
About NEPH
Company Profile
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Company Info
NEPHROS INC
380 Lackawanna Pl
South Orange NEW JERSEY 07079 US
CEO: Andrew Astor
Employees: 31
Phone: 12013435202
NEPHROS INC / NEPH FAQ
What does NEPH do?
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
What is the stock price of NEPHROS INC today?
The current stock price of NEPH is 5.6648 USD. The price decreased by -1.99% in the last trading session.
What is the dividend status of NEPHROS INC?
NEPH does not pay a dividend.
What is the ChartMill rating of NEPHROS INC stock?
NEPH has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the employee count for NEPH stock?
NEPHROS INC (NEPH) currently has 31 employees.
What is the market capitalization of NEPH stock?
NEPHROS INC (NEPH) has a market capitalization of 60.22M USD. This makes NEPH a Micro Cap stock.
What is the Short Interest ratio of NEPHROS INC (NEPH) stock?
The outstanding short interest for NEPHROS INC (NEPH) is 0.07% of its float.
NEPH Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NEPH. When comparing the yearly performance of all stocks, NEPH is one of the better performing stocks in the market, outperforming 98.52% of all stocks.
NEPH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NEPH. NEPH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
NEPH Financial Highlights
Over the last trailing twelve months NEPH reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 244.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.95% | ||
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| Debt/Equity | 0 |
NEPH Forecast & Estimates
8 analysts have analysed NEPH and the average price target is 7.14 USD. This implies a price increase of 26.04% is expected in the next year compared to the current price of 5.6648.
For the next year, analysts expect an EPS growth of 1322977426536356900% and a revenue growth 24.58% for NEPH